These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 34835064)

  • 1. CRISPR Screening: Molecular Tools for Studying Virus-Host Interactions.
    Chulanov V; Kostyusheva A; Brezgin S; Ponomareva N; Gegechkori V; Volchkova E; Pimenov N; Kostyushev D
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR genetic screens to discover host-virus interactions.
    McDougall WM; Perreira JM; Reynolds EC; Brass AL
    Curr Opin Virol; 2018 Apr; 29():87-100. PubMed ID: 29684735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-Cas based targeting of host and viral genes as an antiviral strategy.
    Koujah L; Shukla D; Naqvi AR
    Semin Cell Dev Biol; 2019 Dec; 96():53-64. PubMed ID: 30953741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling Host-Virus Interactions in Viral Infectious Diseases Using Stem-Cell-Derived Systems and CRISPR/Cas9 Technology.
    Kim J; Koo BK; Yoon KJ
    Viruses; 2019 Jan; 11(2):. PubMed ID: 30704043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR/Cas9-Based Antiviral Strategy: Current Status and the Potential Challenge.
    Lee C
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30959782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The application of CRISPR-Cas9 gene editing technology in viral infection diseases].
    Yin LJ; Hu SQ; Guo F
    Yi Chuan; 2015 May; 37(5):412-8. PubMed ID: 25998428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A CRISPR toolbox to study virus-host interactions.
    Puschnik AS; Majzoub K; Ooi YS; Carette JE
    Nat Rev Microbiol; 2017 Jun; 15(6):351-364. PubMed ID: 28420884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Principles and Applications of CRISPR Toolkit in Virus Manipulation, Diagnosis, and Virus-Host Interactions.
    Jamehdor S; Pajouhanfar S; Saba S; Uzan G; Teimoori A; Naserian S
    Cells; 2022 Mar; 11(6):. PubMed ID: 35326449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput genetic screens using CRISPR-Cas9 system.
    Kweon J; Kim Y
    Arch Pharm Res; 2018 Sep; 41(9):875-884. PubMed ID: 29637495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunity and Viral Infections: Modulating Antiviral Response via CRISPR-Cas Systems.
    Brezgin S; Kostyusheva A; Bayurova E; Volchkova E; Gegechkori V; Gordeychuk I; Glebe D; Kostyushev D; Chulanov V
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CRISPR-Cas immune system: biology, mechanisms and applications.
    Rath D; Amlinger L; Rath A; Lundgren M
    Biochimie; 2015 Oct; 117():119-28. PubMed ID: 25868999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Use of CRISPR/Cas9 as a Tool to Study Human Infectious Viruses.
    Lin H; Li G; Peng X; Deng A; Ye L; Shi L; Wang T; He J
    Front Cell Infect Microbiol; 2021; 11():590989. PubMed ID: 34513721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-Wide CRISPR Screen Identifies RACK1 as a Critical Host Factor for Flavivirus Replication.
    Shue B; Chiramel AI; Cerikan B; To TH; Frölich S; Pederson SM; Kirby EN; Eyre NS; Bartenschlager RFW; Best SM; Beard MR
    J Virol; 2021 Nov; 95(24):e0059621. PubMed ID: 34586867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering virus resistance via CRISPR-Cas systems.
    Mahas A; Mahfouz M
    Curr Opin Virol; 2018 Oct; 32():1-8. PubMed ID: 30005359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/CAS9-Mediated Antiviral Activity: A Tool to Combat Viral Infection.
    Ashfaq UA; Khalid H
    Crit Rev Eukaryot Gene Expr; 2020; 30(1):45-56. PubMed ID: 32421984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas Targeting of Host Genes as an Antiviral Strategy.
    Chen S; Yu X; Guo D
    Viruses; 2018 Jan; 10(1):. PubMed ID: 29337866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The CRISPR/Cas system: a genome editing tool to develop animal models of viral infections].
    Castino G; Guillemet M; Joly A; Vignon A
    Med Sci (Paris); 2018 May; 34(5):403-405. PubMed ID: 29900841
    [No Abstract]   [Full Text] [Related]  

  • 18. CRISPR/Cas9 gene editing: A new therapeutic approach in the treatment of infection and autoimmunity.
    Mohammadzadeh I; Qujeq D; Yousefi T; Ferns GA; Maniati M; Vaghari-Tabari M
    IUBMB Life; 2020 Aug; 72(8):1603-1621. PubMed ID: 32344465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9-The ultimate weapon to battle infectious diseases?
    Doerflinger M; Forsyth W; Ebert G; Pellegrini M; Herold MJ
    Cell Microbiol; 2017 Feb; 19(2):. PubMed ID: 27860197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR based genome editing and removal of human viruses.
    Chen YC
    Prog Mol Biol Transl Sci; 2021; 179():93-116. PubMed ID: 33785179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.